Jinan Milin Pharmaceutical Technology Co., Ltd., established in 2012, possesses exceptional R&D capabilities, a comprehensive industrial base, and an international quality management system. The company is primarily dedicated to the research, development, production, and customization of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. It is an innovation-driven modern pharmaceutical enterprise. For over a decade since its inception, the company has focused on researching therapeutic areas such as cardiovascular and cerebrovascular diseases, central nervous system disorders, anti-tumor agents, anti-aging drugs, and antibacterial medications. Representative products include: Apixaban, Lurasidone, Vortioxetine, Edoxaban, Sacituzumab Govitecan, β-Nicotinamide Mononucleotide, Indacaterol, and their intermediates. With assured product quality and a broad market, the company has established long-term and friendly cooperative relationships with clients in Egypt, Japan, India, Russia, and other countries.

Milin Pharmaceutical has a 1,500-square-meter R&D center in the Zhongguancun E-Valley (Qihe) incubator, equipped with comprehensive testing instruments such as high-performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) spectrometers, liquid chromatography-mass spectrometry (LC-MS) systems, and automatic polarimeters, capable of supporting small-scale process research under various conditions. The pilot plant is equipped with 50L and 100L glass reactors, high and low-temperature equipment, and can conduct organic chemical reactions ranging from -100°C to 200°C. Additionally, the company has a production base in Linyi with multiple independent production lines, including: a 20-ton/year Apixaban intermediate production line and a 10-ton/year Lurasidone intermediate production line, capable of meeting batch production needs for various products. The technical team consists of high-end talents specializing in pharmaceuticals, biopharmaceuticals, chemical synthesis, and other related fields, with doctoral degree holders accounting for 10% and master's degree holders for 15%. The team is young, dynamic, innovative, and ready to embrace challenges.

Adhering to the business philosophy of "dedication and innovation," Milin Pharmaceutical persists in pioneering and innovating, continuously improving its quality system, vigorously introducing technical and managerial talents, building an elite team, and serving customers wholeheartedly. We look forward to sincere cooperation, mutual development, and shared progress with you.